Cannabis Bioscience International Holdings (CBIH) Net Cash Flow (2022 - 2025)
Historic Net Cash Flow for Cannabis Bioscience International Holdings (CBIH) over the last 6 years, with Q3 2025 value amounting to -$103712.0.
- Cannabis Bioscience International Holdings' Net Cash Flow fell 4856355.14% to -$103712.0 in Q3 2025 from the same period last year, while for Aug 2025 it was -$91729.0, marking a year-over-year decrease of 232862.06%. This contributed to the annual value of $12197.0 for FY2025, which is 24950.97% up from last year.
- Latest data reveals that Cannabis Bioscience International Holdings reported Net Cash Flow of -$103712.0 as of Q3 2025, which was down 4856355.14% from $12404.0 recorded in Q2 2025.
- Cannabis Bioscience International Holdings' 5-year Net Cash Flow high stood at $362012.0 for Q1 2023, and its period low was -$103712.0 during Q3 2025.
- Over the past 4 years, Cannabis Bioscience International Holdings' median Net Cash Flow value was -$246.5 (recorded in 2024), while the average stood at $20271.4.
- Within the past 5 years, the most significant YoY rise in Cannabis Bioscience International Holdings' Net Cash Flow was 3190512.82% (2025), while the steepest drop was 4856355.14% (2025).
- Over the past 4 years, Cannabis Bioscience International Holdings' Net Cash Flow (Quarter) stood at -$2340.0 in 2022, then plummeted by 88.46% to -$4410.0 in 2023, then skyrocketed by 100.75% to $33.0 in 2024, then tumbled by 314378.79% to -$103712.0 in 2025.
- Its Net Cash Flow stands at -$103712.0 for Q3 2025, versus $12404.0 for Q2 2025 and -$454.0 for Q1 2025.